Quantum BioPharma Ltd. Cash And Cash Equivalents
Quantum BioPharma Ltd. (QNTM) had Cash And Cash Equivalents of $1.91 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-26
- 2019-12-31: Cash And Cash Equivalents 7.93M CAD.
- 2018-12-31: Cash And Cash Equivalents 21.13M CAD.
- 2017-12-31: Cash And Cash Equivalents 4.74M CAD.
CAD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2019-12-31 | 7.93M CAD 40-F/A · filed 2020-03-17 |
| 2018-12-31 | 21.13M CAD 40-F/A · filed 2020-03-17 |
| 2017-12-31 | 4.74M CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $1.91M 20-F · filed 2026-03-26 |
| 2025-09-30 | $445.94K 6-K · filed 2025-11-06 |
| 2025-06-30 | $1.50M 6-K · filed 2025-08-07 |
| 2025-03-31 | $3.52M 6-K/A · filed 2025-06-16 |
| 2024-12-31 | $6.00M 20-F · filed 2026-03-26 |
| 2024-09-30 | $3.12M 6-K · filed 2025-11-06 |
| 2024-06-30 | $3.31M 6-K · filed 2025-08-07 |
| 2024-03-31 | $1.33M 6-K/A · filed 2025-06-16 |
| 2023-12-31 | $2.76M 20-F · filed 2026-03-26 |
| 2022-12-31 | $16.98M 20-F · filed 2026-03-26 |
| 2021-12-31 | $35.26M 20-F · filed 2023-03-31 |
| 2020-12-31 | $17.52M 20-F · filed 2023-03-31 |
| 2019-12-31 | $5.97M 20-F · filed 2023-03-31 |
| 2019-01-01 | $15.90M 40-F · filed 2021-03-17 |
| 2018-12-31 | $15.90M 20-F · filed 2022-03-31 |